Delivery Order SPE2DB25D3504-SPE2DB25FVVRW
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 100 mg tablets. The contract has a ceiling value of $1,464.53 and a period of performance ending on September 24, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $1,827.19 and covers the delivery of 4,568,198,149 tablets of Lamotrigine ER 200 mg, a medication used to treat epilepsy and bipolar disorder. The contract has an ultimate completion date of May 12, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery...
- This is a $1,065.82 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count bottles of 200 mg Lamotrigine ER tablets, which are used to treat certain types of seizures. The contract has a completion date of June 24, 2025 and is not set aside for any small business category. AmerisourceBergen Drug Corp is the prime...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,596.03, is for the delivery of Lamotrigine ER 300 mg tablets, a medication used to treat seizures and certain types of mental health conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite...
- This is a $1,982.65 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lamotrigine extended-release 300 mg tablets to support federal healthcare programs. It has an ultimate completion date of March 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4566320992 units of Lamotrigine ODT 100 mg Tablets. The contract has a ceiling value of $1,564.64 and will run through November 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $373,000 to Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, to provide 4561970222 lamotrigine ER 300 mg tablets (30 count) in support of Department of Defense requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period concluding on August 29, 2023. The order was placed under an existing DLA-wide supply...
- The Defense Logistics Agency awarded a $751.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 30 lamotrigine ER 300 mg tablets. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by September 15, 2023 in support of the Defense Logistics Agency's medical supply chain requirements. No major subcontractors or set aside designations were indicated. The delivery order was issued under an existing...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $35,660 firm fixed price delivery order contract to provide 4562339082 Lamotrigine ER 25 MG tablets. As the prime contractor, Amerisourcebergen will deliver 30 count bottles of the generic anti-seizure medication to a Defense Department facility located in Conshohocken, Pennsylvania between September 28-29, 2023. The contract was awarded under the parent company Amerisourcebergen Corporation's Federal Supply Schedule...
- This federal contract award, valued at $1,043.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4567998899 LAMOTRIGINE ER 200 MG TABLET 30S, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVRWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar disorder, reflecting the Department of Defense's ongoing pharmaceutical procurement needs for military healthcare systems. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen leverages this comprehensive IDC to supply a broad range of medications, vaccines, and medical devices to support military healthcare programs globally. The company's extensive portfolio of federal contracts and demonstrated capability to compete successfully across open procurement demonstrate its importance within the Defense Health Agency's supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |